Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study Meeting Abstract
| Authors: | Vergote, I. B.; Monk, B. J.; O'Cearbhaill, R. E.; Westermann, A. M.; Banerjee, S.; Collins, D. C.; Mirza, M. R.; O'Malley, D.; Gennigens, C.; Pignata, S.; Melichar, B.; Sadozye, A.; Forget, F.; Tewari, K. S.; Gort, E.; Soumaoro, I.; Mondrup Andreassen, C.; Nicacio, L. V.; Van Nieuwenhuysen, E.; Lorusso, D. |
| Abstract Title: | Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S726 |
| End Page: | S727 |
| Language: | English |
| ACCESSION: | WOS:000700527701189 |
| DOI: | 10.1016/j.annonc.2021.08.1166 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract #723MO -- Source: Wos |
